4000点再现，资本奔赴硬科技丨经济有数

Core Insights - The article discusses the emergence of new investment opportunities in China, particularly in the fields of robotics, artificial intelligence (AI), and innovative pharmaceuticals, collectively referred to as the "new new three" [5][6][29] Group 1: Robotics - The Chinese humanoid robot industry is rapidly developing, with 5,688 patents filed in the last five years, leading globally [8][10] - The market for humanoid robots in China is projected to grow from 1.245 billion yuan in 2024 to 25.404 billion yuan by 2030 [8] - Major companies like Yushutech are gaining attention, with significant market valuations and advancements in humanoid robotics [8][12] Group 2: Artificial Intelligence - China's AI industry is entering a new development phase, with 1,509 large models and over 5300 AI companies, contributing to approximately 70% of the industry scale [14][18] - The AI industry in China is expected to exceed 900 billion yuan in 2024, reflecting a 24% year-on-year growth [15][23] - The number of AI-related patents has surpassed 1.576 million, positioning China as a global leader in AI innovation [22] Group 3: Innovative Pharmaceuticals - Chinese innovative drugs are gaining international traction, with total licensing agreements reaching $87.4 billion in the first eight months of 2025 [25][27] - The market for innovative pharmaceuticals is expected to see significant growth, with companies like BeiGene and HengRui Pharmaceuticals leading the charge [25][29] - The "new new three" sectors, including innovative drugs, are attracting substantial capital, with the innovative drug index showing a remarkable 44.42% increase [29][30] Group 4: Investment Trends - The "new new three" sectors are becoming the most crowded investment areas, with significant trading volumes projected to exceed 12 trillion yuan for robotics and 15 trillion yuan for AI in 2025 [29][31] - The average return rates for thematic funds in these sectors are over 25%, indicating strong investor interest and confidence [29][32] - The performance of these sectors is reflected in the stock indices, with substantial year-to-date gains across robotics, AI, and innovative pharmaceuticals [30][31]